Article Details

Regulus Therapeutics (RGLS) Upgraded to Buy at Zacks Investment Research

Retrieved on: 2019-03-29 22:32:55

Tags for this article:

Click the tags to see associated articles and topics

Regulus Therapeutics (RGLS) Upgraded to Buy at Zacks Investment Research. View article details on hiswai:

Excerpt

<div><b>Renaissance Technologies</b> LLC lifted its holdings in shares of Regulus Therapeutics Inc (NASDAQ:RGLS) by 396.3% during the 3rd quarter, ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up